MedTech

ms-nandita-singh-editor-biospectrum-asia

Is China bioscience really slowing down?

  • China
  • |
  • Opinion

Is China bioscience slowing down? From the numbers that have been put together by the BioSpectrum Asia Pacific Bioscience Industry Survey 2013, it does look so. However, a little deeper look clearly shows that China is not slowing down... Read more

vela-diagnostics-pcr-based-research-use-only-will-identify-new-strain-of-bird-flu-h7n9-and-coronavirus-hcov-emc

Molecular diagnostics is key to future


  • Japan
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

China, Japan, India and Singapore are leveraging on genetic technologies to develop molecular diagnostic platform which is... Read more

dr-rodney-herring-professor-of-mechanical-engineering-and-director-of-advanced-microscopy-facility-university-of-victoria-canada-standing-beside-the-stehm

World's most powerful microscope ready for use


  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The world's most powerful microscope, which resides in a specially constructed room at the University of Victoria,... Read more

universal-biosensors-ubi-has-bagged-technology-in-manufacturing-award-at-victorian-manufacturing-hall-of-fame-awards-ceremony

Universal Biosensors gets manufacturing award

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australia-based Universal Biosensors (UBI) has bagged ‘Technology in Manufacturing Award' at Victorian Manufacturing Hall of... Read more

ema-chmp-gives-thumbs-up-to-pomalidomide-celgene-pomalidomide-for-treatment-of-multiple-myeloma-in-combination-with-dexamethasone

New medtech market infographic published

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Medical Device and Diagnostic Industry (MD+DI) recently published an original infographic and supporting article titled 'The... Read more

mr-mario-pennisi-ceo-life-sciences-queensland-australia

LSQ: Financial crunch makes capital harder to get

  • Australia
  • |
  • Influencers
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

Life Sciences Queensland (LSQ), Australia, offers opportunity for industry stakeholders to come together and cooperate to grow their businesses... Read more

karolinska-instituet-university-of-glasgow-study-dna-variation-in-human-s-irgm-gene-increases-levels-of-gut-microbe-prevotella

Qiagen expands its assay panels for NGS offerings

Singapore: Qiagen N V announced plans to significantly expand its existing portfolio of molecular assays used in next-generation sequencing... Read more

money-invested-research-center

Apollo near deal to acquire MidCap, say sources

Singapore: New York- based business loans provider Apollo Investment is nearing the closure of an agreement to buy MidCap Financial LLC,... Read more

dr-michelle-carr-director-telezon-australia

Telezon rides on CoreIT technology, drives SoloFlow adoption

  • Australia
  • |
  • Influencers
  • |
  • By Nandita Singh
  • |
  • 0 Comment

Australia-based Telezon Limited's CoreIT and SoloFlow Reconstitution Needle technology have already made a mark for itself in the market... Read more

all-domains-of-agilent-s-business-witnesses-considerable-growth-during-q1-2013

NextDocs expands customer list by more than 10%

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: NextDocs, the global leader in compliance solutions for regulated industries, announced that it has expanded its client roster... Read more

www

Singapore starts medtech site to address investment queries

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Singapore has launched medtech portal, www.medtech.sg, that aims to address international investors' queries on relevant and... Read more

19b-biospectrum-asia-top-20-survey-rank-19-china-resources-sanjiu-medical-pharmaceutical-china

China Resources Sanjiu looks ahead at acquisitions for growth

  • China
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

To enhance its market opportunities and drive business growth, China Resources Sanjiu Medical & Pharmaceutical is adopting an acquisition... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X